Trial Profile
Study of elbasvir-grazoprevir (Zepatier) for the treatment of chronic hepatitis C in post kidney transplant patient
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2018
Price :
$35
*
At a glance
- Drugs Elbasvir/grazoprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 13 Jul 2018 New trial record
- 06 Jun 2018 Results presented at the 2018 American Transplant Congress